US$ 25.55
generic glp-1 receptor agonists Liraglutide Approved, Marking First Generic RA Indicated Specifically for Weight Management in the US Manufacturers must adapt to growing
Description
Front Immunol (2018) 9:1291

Abstract Background Glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium glucose co-transporter-2 (SGLT-2) inhibitors reduce cardiorenal outcomes

Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2
The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells

Tsapas A, Avgerinos I, Karagiannis T et al (2020) Comparative effectiveness of glucose-lowering drugs for type 2 diabetes: a systematic review and network meta-analysis

doi: 10.1007/s00125-018-4654-7
